Unlock instant, AI-driven research and patent intelligence for your innovation.

Azilsartan crystal and its preparation method and application

A technology of crystals and crystals, applied in the field of azilsartan crystals and its preparation, can solve the problems of poor stability, many impurities, poor solubility of azilsartan, etc., and achieve good solubility, high purity, and safe production and preparation process Effect

Inactive Publication Date: 2016-07-06
SHANGHAI INST OF PHARMA IND CO LTD +1
View PDF6 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0007] The technical problem to be solved by the present invention is to provide an azilsartan crystal and its preparation method and application

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Azilsartan crystal and its preparation method and application
  • Azilsartan crystal and its preparation method and application
  • Azilsartan crystal and its preparation method and application

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0036] Preparation of Crude Azilsartan

[0037] References J.Med.Chem, 1996,39,5228-5235, 1-[[2'-(2,5-dihydro-5-oxo-1,2,4-oxadiazol-3-yl ) [1,1'-biphenyl]-4-yl]methyl]-2-ethoxy-1H-benzimidazole-7-carboxylic acid methyl ester compound 100.0 g, placed in a reaction flask, added 0.4 mol / L sodium hydroxide 1700ml, react at 73-75°C for 2 hours. After the reaction, cool to room temperature, add dropwise acid aqueous solution to pH=3-4, and precipitate azilsartan crude product.

Embodiment 2

[0039] Put 3 g of the crude product of azilsartan prepared in Example 1 into a reaction flask, add 100 ml of tetrahydrofuran, stir at reflux at 65° C. for 1 hour, heat filter, and naturally cool and crystallize the filtrate to obtain 2.5 g of a solid, which is azilsartan crystals. HPLC purity 99.87%.

[0040] X-ray powder diffraction spectrum, DSC spectrum, TGA spectrum, infrared spectrum are respectively as attached figure 1 , 2 , 3, 4 shown.

[0041]figure 1 The detailed data in the X-ray powder diffraction pattern are shown in Table 1.

[0042] The X-ray powder diffraction data of the azilsartan crystal of table 1 embodiment 1

[0043]

[0044]

[0045] In Table 1, the characteristic diffraction peaks of the crystal of the present invention are: 6.889±0.2°, 7.638±0.2°, 8.664±0.2°, 9.080±0.2°, 10.500±0.2°, 12.691±0.2°, 16.423±0.2°, 18.316± 0.2°, 18.61±0.2°, 19.2854±0.2°, 19.898±0.2°, 20.333±0.2°, 21.417±0.2°, 21.772±0.2°, 22.996±0.2°, 23.489±0.2°, 25.168±0.2°, 25.6...

Embodiment 3

[0051] Add 50 g of the crude product of azilsartan obtained in Example 1, add 200 ml of ethanol, beat and wash at 10-30 ° C for 1 h, and obtain 45 g of anhydrous azilsartan crystals (for the preparation method of anhydrous azilsartan crystals, please refer to literature J .Med.Chem, 1996,39,5228-5235), its X-ray powder diffraction pattern is shown in Figure 5 . Add 100ml of THF to 10g of the obtained azilsartan anhydrous crystal, stir the suspension at 10-30°C for 2h, filter to obtain a solid, and obtain 8.5g of the azilsartan crystal of the present invention, with an HPLC purity of 99.91%. Its X-ray powder diffraction pattern is as figure 1 shown.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
melting pointaaaaaaaaaa
solubility (mass)aaaaaaaaaa
melting pointaaaaaaaaaa
Login to View More

Abstract

The invention discloses an azilsartan crystal, a preparation method and an application thereof. The crystal has the following characteristic diffraction peaks in X-ray powder diffraction: 6.889+ / -0.2 degrees, 7.638+ / -0.2 degrees, 8.664+ / -0.2 degrees, 9.080+ / -0.2 degrees, 10.500+ / -0.2 degrees, 12.691+ / -0.2 degrees, 16.423+ / -0.2 degrees, 18.316+ / -0.2 degrees, 18.61+ / -0.2 degrees, 19.2854+ / -0.2 degrees, 19.898+ / -0.2 degrees, 20.333+ / -0.2 degrees, 21.417+ / -0.2 degrees, 21.772+ / -0.2 degrees, 22.996+ / -0.2 degrees, 23.489+ / -0.2 degrees, 25.168+ / -0.2 degrees, 25.601+ / -0.2 degrees, and 26.609+ / -0.2 degrees. The azilsartan crystal has good dissolvability and stability, a low impurity content, and a simple preparation method.

Description

technical field [0001] The invention relates to the field of medicinal chemistry, in particular to an azilsartan crystal, a preparation method and application thereof. Background technique [0002] The polycrystalline drug is one of the factors that affect the quality of the drug. It has a non-negligible impact on the preparation of raw materials and pharmaceutical preparations, as well as the stability, dissolution and bioavailability of the preparations, and some even bring toxic side effects. Therefore, it is of great significance to study the crystals of drugs. [0003] Azilsartan (Azilsartan, see compound 1 for structural formula) is the latest antihypertensive drug on the market, developed by Takeda Pharmaceutical in Japan, and was approved in Japan on January 28, 2012. Azilsartan is a selective angiotensin Ⅱ receptor antagonist, which can competitively and reversibly block the combination of angiotensin and AT1 receptors to lower blood pressure. The affinity for AT1 ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C07D413/10A61K31/4245A61P9/12
CPCC07D413/10
Inventor 王小梅隋强唐超刘帅欧阳群香时惠麟
Owner SHANGHAI INST OF PHARMA IND CO LTD